(-)-Epigallocatechin-3-gallate protects mice from concanavalin A-induced hepatitis through suppressing immune-mediated liver injury

Clinical and Experimental Immunology

Volumn 145, Issue 3, 2006, Pages 485-492

  Wang, Y ^a   Mei, Y ^a   Feng, D ^b   Xu, L ^a,b,c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^c Building I ^*  (China)

Author keywords

( ) epigallocatechin 3 gallate; Concanavalin A induced hepatitis; Immune mediated liver injury

Indexed keywords

ALANINE AMINOTRANSFERASE; CONCANAVALIN A; EPIGALLOCATECHIN GALLATE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INDUCIBLE NITRIC OXIDE SYNTHASE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; NITRITE; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME SYNTHESIS; GENE EXPRESSION; HEPATITIS; IMMUNE MEDIATED INJURY; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; INFLAMMATION; INFLAMMATORY INFILTRATE; LIVER CELL; LIVER INJURY; LIVER PROTECTION; MALE; MEDIATOR RELEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TEA;

ALANINE TRANSAMINASE; ANIMALS; APOPTOSIS; CATECHIN; CHEMOKINES, CXC; CONCANAVALIN A; HEPATITIS, TOXIC; HEPATOCYTES; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; LIVER; MACROPHAGE INFLAMMATORY PROTEIN-1; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33747446926     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03137.x     Document Type: Article

References (38)

1. Suganuma M, Okabe S, Sueoka N et al. Green tea and cancer chemoprevention. Mutat Res 1999; 428:339-44.
2. Yang F, de Villiers WJ, McClain CJ et al. Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. J Nutr 1998; 128:2334-40.
3. Lin YL, Lin JK. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB. Mol Pharmacol 1997; 52:465-72.
4. Yang GY, Liao J, Kim K et al. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis 1998; 19:611-6.
5. Liang YC, Lin-Shiau SY, Chen CF et al. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3- gallate. J Cell Biochem 1999; 75:1-12.
6. Lu YP, Lou YR, Xie JG et al. Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice. Proc Natl Acad Sci USA 2002; 99:12455-60.
7. Yang F, Oz HS, Barve S et al. Varilek GW. The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6. Mol Pharmacol 2001; 60:528-33.
8. Aktas O, Prozorovski T, Smorodchenko A et al. Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis. J Immunol 2004; 173:5794-800.
9. Chen JH, Tipoe GL, Liong EC et al. Green tea polyphenols prevent toxin-induced hepatotoxicity in mice by down-regulating inducible nitric oxide-derived prooxidants. Am J Clin Nutr 2004; 80:742-51.
10. Song EK, Hur H, Han MK. Epigallocatechin gallate prevents autoimmune diabetes induced by multiple low doses of streptozotocin in mice. Arch Pharm Res 2003; 26:559-63.
11. Kaneko Y, Harada M, Kawano T et al. Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J Exp Med 2000; 191:105-14.
12. Miyazawa Y, Tsutsui H, Mizuhara H et al. Involvement of intrasinusoidal hemostasis in the development of concanavalin A-induced hepatic injury in mice. Hepatology 1998; 27:497-506.
13. Tiegs G, Hentschel J, Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 1992; 90:196-203.
14. Mizuhara H, O'Neill E, Seki N et al. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J Exp Med 1994; 179:1529-37.
15. Gantner F, Leist M, Lohse AW et al. Concanavalin A-induced T cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 1995; 21:190-8.
16. Mizuhara H, Uno M, Seki N et al. Critical involvement of interferon gamma in the pathogenesis of T cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis. Hepatology 1996; 23:1608-15.
17. H Moshage B Kok JR Huizenga PL Jansen. Nitrite and nitrate determinations in plasma: a critical evaluation. Clin Chem 1995; 41:892-6.
18. Kusters S, Gantner F, Kunstle G. Interferon-ã plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 1996; 111:462-71.
19. Yoneda M, Wada K, Katayama K et al. A novel therapy for acute hepatitis utilizing dehydroepiandrosterone in the murine model of hepatitis. Biochem Pharmacol 2004; 68:2283-9.
20. Tamaru M, Nishioji K, Kobayashi Y et al. Liver-infiltrating T lymphocytes are attracted selectively by IFN-inducible protein-10. Cytokine 2000; 12:299-308.
21. Nakamura K, Okada M, Yoneda M et al. Macrophage inflammatory protein-2 induced by TNF-alpha plays a pivotal role in concanavalin A-induced liver injury in mice. J Hepatol 2001; 35:217-24.
22. Trautwein C, Rakemann T, Brenner DA et al. Concanavalin A-induced liver cell damage: activation of intracellular pathways triggered by tumor necrosis factor in mice. Gastroenterology 1998; 114:1035-45.
23. Wolf D, Schumann J, Koerber K et al. Low molecular-weight hyaluronic acid induces nuclear factor-κB-dependent resistance against tumor necrosis factor α-mediated liver injury in mice. Hepatology 2001; 34:535-47.
24. Rogers J, Perkins I, van Olphen A et al. Epigallocatechin gallate modulates cytokine production by bone marrow-derived dendritic cells stimulated with lipopolysaccharide or muramyldipeptide, or infected with Legionella pneumophila. Exp Biol Med 2005; 230:645-51.
25. Haqqi TM, Anthony DD, Gupta S et al. Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. Proc Natl Acad Sci USA 1999; 96:4524-9.
26. Siebler J, Wirtz S, Klein S et al. A key pathogenic role for the STAT1/T-bet signaling pathway in T cell-mediated liver inflammation. Hepatology 2003; 38:1573-80.
27. Neish AS, Read MA, Thanos D et al. Endothelial interferon regulatory factor 1 cooperates with NF-κB as a transcriptional activator of vascular cell adhesion molecule 1. Mol Cell Biol 1995; 15:2558-69.
28. Hong F, Jaruga B, Kim WH et al. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. J Clin Invest 2002; 110:1503-13.
29. Streetz K, Fregien B, Plumpe J et al. Dissection of the intracellular pathways in hepatocytes suggests a role for Jun kinase and IFN regulatory factor-1 in ConA-induced liver failure. J Immunol 2001; 167:514-23.
30. Sass G, Koerber K, Bang R et al. Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice. J Clin Invest 2001; 107:439-47.
31. Okamoto T, Masuda Y, Kawasaki T et al. Aminoguanidine prevents concanavalin A-induced hepatitis in mice. Eur J Pharmacol 2000; 396:125-30.
32. Marshall HE, Merchant K, Stamler JS. Nitrosation and oxidant in the regulation of gene expression. FASEB J 2000; 14:1889-900.
33. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol 1997; 15:675-705.
34. Jaruga B, Hong F, Kim WH et al. IFN-gamma/STAT1 acts as a proinflammatory signal in T cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: a critical role of IRF-1. Am J Physiol Gastrointest Liver Physiol 2004; 287:G1044-52.
35. Ajuebor MN, Das AM, Virag L et al. Regulation of macrophage inflammatory protein-1 alpha expression and function by endogenous interleukin-10 in a model of acute inflammation. Biochem Biophys Res Commun 1999; 255:279-82.
36. Olson TS, Ley K. Chemokines and chemokine receptors in leukocyte trafficking. Am J Physiol Regul Integr Comp Physiol 2002; 283:R7-28.
37. Salazar-Mather TP, Orange JS, Biron CA. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways. J Exp Med 1998; 187:1-14.
38. Ajuebor MN, Hogaboam CM, Le T et al. CCL3/MIP-1alpha is proinflammatory in murine T cell-mediated hepatitis by recruiting CCR1-expressing CD4(+) T cells to the liver. Eur J Immunol 2004; 34:2907-18.